Lucia Demková

483 total citations
15 papers, 334 citations indexed

About

Lucia Demková is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lucia Demková has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Lucia Demková's work include Cancer Cells and Metastasis (5 papers), Mesenchymal stem cell research (3 papers) and Immunotherapy and Immune Responses (3 papers). Lucia Demková is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Mesenchymal stem cell research (3 papers) and Immunotherapy and Immune Responses (3 papers). Lucia Demková collaborates with scholars based in Slovakia, Czechia and Norway. Lucia Demková's co-authors include Lucia Kučerová, Miroslava Matúšková, Erika Durinikova, Zuzana Kozovská, Silvia Tyčiaková, Božena Smolková, Ján Gurský, Roman Bohovic, Martin Boháč and Véronique Bajzik and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Cancer and eLife.

In The Last Decade

Lucia Demková

15 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucia Demková Slovakia	9	185	161	70	55	42	15	334
Victoria M. Kim United States	8	166 0.9×	236 1.5×	90 1.3×	43 0.8×	116 2.8×	9	416
Shahrokh Abdolahi Iran	7	95 0.5×	156 1.0×	71 1.0×	35 0.6×	75 1.8×	13	311
João Paulo Oliveira–Costa Brazil	11	187 1.0×	212 1.3×	125 1.8×	40 0.7×	34 0.8×	17	407
Zeinab Ghazvinian Iran	6	97 0.5×	152 0.9×	63 0.9×	33 0.6×	68 1.6×	8	283
Candice Alexandra Grzelak United States	8	193 1.0×	199 1.2×	133 1.9×	18 0.3×	46 1.1×	10	420
Francesca Siepi Italy	10	342 1.8×	216 1.3×	66 0.9×	20 0.4×	93 2.2×	12	480
Shaojie Wu China	6	208 1.1×	145 0.9×	96 1.4×	20 0.4×	24 0.6×	21	332
Florence Defresne Belgium	10	161 0.9×	53 0.3×	166 2.4×	23 0.4×	45 1.1×	15	340
Mireia Berdiel‐Acer Spain	9	151 0.8×	207 1.3×	102 1.5×	24 0.4×	53 1.3×	13	313
Takuya Egami Japan	10	192 1.0×	247 1.5×	82 1.2×	11 0.2×	47 1.1×	26	403

Countries citing papers authored by Lucia Demková

Since Specialization

Citations

This map shows the geographic impact of Lucia Demková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Demková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Demková more than expected).

Fields of papers citing papers by Lucia Demková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucia Demková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Demková. The network helps show where Lucia Demková may publish in the future.

Co-authorship network of co-authors of Lucia Demková

This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Demková. A scholar is included among the top collaborators of Lucia Demková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Demková. Lucia Demková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Demková, Lucia, et al.. (2024). The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells. Neoplasma. 71(5). 417–427. 1 indexed citations

Jakubechova, Jana, Božena Smolková, Alena Furdová, et al.. (2023). Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies. International Journal of Molecular Sciences. 24(16). 12957–12957. 4 indexed citations

Tyčiaková, Silvia, Eleftherios Pilalis, Miroslava Matúšková, et al.. (2022). Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression. Frontiers in Pharmacology. 13. 991751–991751. 12 indexed citations

Radaszkiewicz, Tomasz, Katarzyna Anna Radaszkiewicz, Karol Kaiser, et al.. (2021). RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy. eLife. 10. 27 indexed citations

Šoltýsová, Andrea, et al.. (2021). KIT Expression Is Regulated by DNA Methylation in Uveal Melanoma Tumors. International Journal of Molecular Sciences. 22(19). 10748–10748. 2 indexed citations

Kozovská, Zuzana, et al.. (2021). CRISPR: History and perspectives to the future. Biomedicine & Pharmacotherapy. 141. 111917–111917. 28 indexed citations

Šoltýsová, Andrea, Tatiana Sedláčková, Dana Dvorská, et al.. (2020). Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy. International Journal of Molecular Sciences. 21(24). 9651–9651. 12 indexed citations

Smolková, Božena & Lucia Demková. (2020). Epigenetic Changes in Malignant Uveal Melanoma and Possibilities of Their Therapeutic Targeting. PubMed. 76(2). 103–110. 2 indexed citations

Demková, Lucia & Lucia Kučerová. (2018). Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma. Molecular Cancer. 17(1). 26–26. 54 indexed citations

10.

Kozovská, Zuzana, Véronique Bajzik, Erika Durinikova, et al.. (2018). ALDH1A inhibition sensitizes colon cancer cells to chemotherapy. BMC Cancer. 18(1). 656–656. 52 indexed citations

11.

Kučerová, Lucia, et al.. (2016). Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation. BMC Cancer. 16(1). 308–308. 7 indexed citations

12.

Matúšková, Miroslava, Martin Boháč, Erika Durinikova, et al.. (2016). Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells. Cell Communication and Signaling. 14(1). 4–4. 74 indexed citations

13.

Bohovic, Roman, Lucia Demková, Marina Cihova, et al.. (2015). 3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment. Neoplasma. 62(4). 521–530. 7 indexed citations

14.

Kučerová, Lucia, et al.. (2014). Tumor-driven Molecular Changes in Human Mesenchymal Stromal Cells. Cancer Microenvironment. 8(1). 1–14. 23 indexed citations

15.

Kučerová, Lucia, et al.. (2014). Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model. Gene Therapy. 21(10). 874–887. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact